This information is intended for US patients and caregivers to access current scientific information about J&J Innovative Medicine products. It is prepared by Medical Information and is not intended to promote the use of our products, nor to provide medical advice.
Last Updated: 07/15/2024
Here is a passage from the ERLEADA PATIENT INFORMATION which may be helpful to address your question:
Step 1. Remove the plunger out of the syringe (use at least a 50 mL syringe).
Step 2. Add your entire prescribed dose of 60 mg tablets into the syringe body (barrel) and place the plunger back in the syringe. Do not crush or split the tablets.
Step 3. Withdraw 20 mL of non-carbonated water into the syringe.
Step 4. Wait 10 minutes and then shake the syringe very well (vigorously) to break the tablets apart completely.
Step 5. Attach the syringe to the feeding tube and give the mixture right away.
Step 6. Withdraw non-carbonated water into the same syringe and flush through the feeding tube. Repeat Step 6 until no pieces of tablets are left in the syringe or feeding tube.
Step 1. Remove the plunger out of the syringe (use at least a 20 mL syringe).
Step 2. Add one 240 mg tablet into the syringe body (barrel) and place the plunger back in the syringe. Do not crush or split the tablet.
Step 3. Withdraw 10 mL of non-carbonated water into the syringe.
Step 4. Wait 10 minutes and then shake the syringe very well (vigorously) to break the tablet apart completely.
Step 5. Attach the syringe to the feeding tube and give the mixture right away.
Step 6. Withdraw non-carbonated water into the same syringe and flush through the feeding tube. Repeat Step 6 until no pieces of tablet are left in the syringe or feeding tube.
This information is provided ONLY in response to your request and is not intended as medical advice, to promote the use of our product, or suggest using it in any manner other than as described in the PRESCRIBING INFORMATION. All decisions regarding your medical treatment should be made with your healthcare professional(s). Please contact your healthcare professional(s) to discuss the information in this response.
Please refer to the attached full PRESCRIBING INFORMATION, PATIENT INFORMATION, and the INSTRUCTIONS FOR USE for ERLEADA.1
1 | ERLEADA (apalutamide) [Prescribing Information]. Horsham, PA: Janssen Products, LP;https://www.janssenlabels.com/package-insert/product-monograph/prescribing-information/ERLEADA-pi.pdf. |